Sejin Son
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 9
- Immunology 16
- Immunotherapy and Immune Responses 13
- Co-authors
- Jutaek Nam (17 shared papers)James Jaehyun Moon (13 shared papers)Won Jong Kim (13 shared papers)Kyong Soo Park (4 shared papers)Anna A. Schwendeman (3 shared papers)Rui Kuai (2 shared papers)Weiping Zou (2 shared papers)Lonnie D. Shea (1 shared paper)
- Journals
- Biomaterials (7 papers)Journal of Controlled Release (5 papers)Advanced Science (3 papers)Biomaterials Research (2 papers)Nano Letters (2 papers)
- Partner nations
- South KoreaUnited StatesChina
In The Last Decade
Sejin Son
55 papers receiving 4.6k citations
Sejin Son's Hit Papers
Peers
Comparison fields: 5 of 112
- Biomaterials 1.4k
- Biomedical Engineering 2.6k
- Immunology 1.0k
- Pharmaceutical Science 174
- Molecular Biology 1.9k
Countries citing papers authored by Sejin Son
This map shows the geographic impact of Sejin Son's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sejin Son with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sejin Son more than expected).
Fields of papers citing papers by Sejin Son
This network shows the impact of papers produced by Sejin Son. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sejin Son. The network helps show where Sejin Son may publish in the future.
Co-authors
The 25 scholars most cited alongside Sejin Son, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer nanomedicine for combination cancer immunotherapy Hit paper breakdown → | 2019 | 856 |
| 2 | Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer Hit paper breakdown → | 2018 | 730 |
| 3 | 2018 | 322 | |
| 4 | 2016 | 297 | |
| 5 | 2011 | 234 | |
| 6 | 2011 | 208 | |
| 7 | 2014 | 125 | |
| 8 | 2010 | 118 | |
| 9 | 2010 | 117 | |
| 10 | 2014 | 117 | |
| 11 | 2009 | 95 | |
| 12 | 2012 | 91 | |
| 13 | 2020 | 84 | |
| 14 | 2014 | 81 | |
| 15 | 2021 | 79 | |
| 16 | 2020 | 71 | |
| 17 | 2016 | 71 | |
| 18 | 2015 | 67 | |
| 19 | 2012 | 65 | |
| 20 | 2011 | 63 |
About Sejin Son
Sejin Son is a scholar working on Biomaterials, Immunology, Biomedical Engineering, Molecular Biology and Oncology, having authored 56 papers that have together received 4.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (14 papers), Immunotherapy and Immune Responses (13 papers), Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Ultrasound and Hyperthermia Applications (5 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Biomaterials (1.4k citations), Biomedical Engineering (2.6k citations), Immunology (1.0k citations), Pharmaceutical Science (174 citations) and Molecular Biology (1.9k citations). Sejin Son has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Jutaek Nam, James Jaehyun Moon, Won Jong Kim, Kyong Soo Park, Anna A. Schwendeman, Rui Kuai, Weiping Zou, Lonnie D. Shea, Lukasz J. Ochyl and Kaushik Singha. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Advanced Science, Biomaterials Research and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.